Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. PHR
PHR logo

PHR Overview

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Loading chart...

High
11.470
Open
11.340
VWAP
11.08
Vol
765.89K
Mkt Cap
676.84M
Low
10.830
Amount
8.49M
EV/EBITDA(TTM)
14.63
Total Shares
61.81M
EV
702.01M
EV/OCF(TTM)
7.99
P/S(TTM)
1.38
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
Show More

Events Timeline

(ET)
2026-06-11
14:30:00
Jeff Bezos' New AI Venture Prometheus Raises $12B, Valuation Reaches $41B
select
2026-05-27 (ET)
2026-05-27
19:50:00
WTI Crude Oil Falls Below $90, Energy Sector Worst Performer
select

News

Globenewswire
7.0
07-07Globenewswire
Phreesia Faces Class Action Lawsuit Impacting Stock Price
  • Class Action Filed: Pomerantz LLP has announced a class action lawsuit against Phreesia, alleging that the company and certain officers may have engaged in securities fraud or other unlawful business practices, which could expose the company to significant legal risks.
  • Stock Price Plummets: Following Phreesia's announcement on March 30, 2026, of significantly reduced revenue growth projections for fiscal year 2027, the stock price fell by $3.03, or 26.56%, closing at $8.38 per share, reflecting market pessimism regarding the company's outlook.
  • Revised Financial Guidance: The company attributed the revenue shortfall to macroeconomic factors, including “worsening visibility” and weaker pharmaceutical marketing commitments within its Network Solutions segment, indicating vulnerability in the current economic climate.
  • Investor Action Deadline: Investors are advised to apply by July 13, 2026, to be appointed as Lead Plaintiff in the class action, suggesting that the lawsuit may attract significant attention from affected investors, further exacerbating market unease regarding Phreesia.
Globenewswire
7.0
07-07Globenewswire
Phreesia Faces Shareholder Class Action Lawsuit
  • Lawsuit Background: Phreesia, Inc. (NYSE: PHR) is facing a shareholder class action lawsuit alleging that the company made false and misleading statements while failing to disclose risks associated with slowing growth in its Network Solutions segment, which has adversely affected investor decisions.
  • Investor Impact: The lawsuit targets investors who purchased Phreesia shares between May 8, 2025, and March 30, 2026, encouraging those who experienced losses during this period to contact legal counsel to understand their rights, highlighting a significant concern for transparency among investors.
  • Legal Representation: Holzer & Holzer, LLC, a top-rated securities litigation law firm, has been instrumental in recovering hundreds of millions for defrauded shareholders since its inception in 2000, demonstrating a strong commitment to protecting investor rights and interests.
  • Lawsuit Deadline: Investors must apply to be appointed lead plaintiff by July 13, 2026, emphasizing the importance of timely action in legal proceedings to ensure their rights are effectively safeguarded.
Globenewswire
7.0
07-07Globenewswire
Multiple Companies Facing Class Action Lawsuits
  • Phreesia Lawsuit: Phreesia Inc. is facing allegations for misleading investors during the period from May 2025 to March 2026 by claiming reliable long-term growth prospects, while the sustainability of its pharmaceutical marketing commitments was uncertain, potentially jeopardizing its 2027 revenue targets.
  • Sportradar Violations: Sportradar Group AG is accused of collaborating with black-market gambling operators from November 2024 to April 2026, despite assurances of legal compliance, leading to materially misleading statements about its business prospects.
  • Commvault Sales Issues: Commvault Systems Inc. is under scrutiny for failing to disclose the impact of different sales types on annual recurring revenue (ARR) growth from January 2025 to January 2026, resulting in misleading positive statements about its business outlook.
  • Veritone Financial Misconduct: Veritone, Inc. is facing allegations of inaccurately recording and misclassifying revenue from October 2025 to April 2026, necessitating a restatement of financial statements, which severely undermines investor confidence in the company's operations.
Globenewswire
7.0
07-06Globenewswire
Phreesia Faces Class Action Lawsuit; Investors Encouraged to Contact Attorneys
  • Class Action Filed: Bragar Eagel & Squire has initiated a class action lawsuit against Phreesia in the U.S. District Court for Delaware on behalf of investors who purchased shares between May 8, 2025, and March 30, 2026, with a deadline of July 13, 2026, to apply as lead plaintiff.
  • Allegations Overview: The lawsuit alleges that Phreesia and its executives violated federal securities laws by failing to disclose the true state of slowing demand and reduced visibility in key revenue streams, particularly weakened pharmaceutical marketing commitments in its Network Solutions segment.
  • Revenue Guidance Cut: On March 30, 2026, Phreesia revised its fiscal 2027 revenue guidance down to $510-$520 million, a reduction of $35 million to $49 million from the previous range, resulting in a stock price drop of 21% to 28%.
  • Management Misrepresentation: CFO Balaji Gandhi previously indicated on the December 2025 earnings call that the selling season for network solutions was progressing well, without mentioning any risks, leading to investor misconceptions about the company's outlook.
Globenewswire
7.0
07-06Globenewswire
Multiple Companies Face Class Action Lawsuits
  • Phreesia Lawsuit: Phreesia Inc. is facing allegations for misleading investors about its long-term growth outlook during the period from May 2025 to March 2026, claiming reliable revenue growth while the uncertainty of its pharmaceutical marketing commitments jeopardizes the 2027 revenue target, resulting in investor losses.
  • Sportradar Violations: Sportradar Group AG is accused of collaborating with black-market gambling operators from November 2024 to April 2026, despite assurances of legal compliance, which has severely undermined investor confidence in the company's operations and prospects.
  • Commvault Sales Issues: Commvault Systems Inc. is facing claims for failing to disclose the impact of sales types on annual recurring revenue (ARR) growth from April 2025 to January 2026, leading to materially misleading positive statements that harmed investor interests.
  • Veritone Financial Misconduct: Veritone, Inc. is accused of inaccurately recording revenue and costs from October 2025 to April 2026, necessitating a restatement of financial statements, which has significantly affected investor trust in the company's financial health.
Globenewswire
7.0
07-05Globenewswire
Phreesia Faces Class Action Lawsuit from Investors
  • Lawsuit Background: Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Phreesia, Inc., aiming to recover damages for investors who purchased securities between May 8, 2025, and March 30, 2026, highlighting significant investor concerns regarding the company's financial transparency.
  • Allegations: The complaint alleges that Phreesia failed to disclose slowing demand and diminished visibility into key revenue streams during the class period, which severely undermined investor confidence in the company's prospects and could lead to further declines in stock price.
  • Legal Process: Investors must apply to be lead plaintiffs by July 13, 2026, indicating the urgency of the case and the protection of investor rights, reflecting the regulatory scrutiny over the securities market.
  • Law Firm's Strength: Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that has recovered hundreds of millions for investors, emphasizing its expertise and successful track record in securities fraud class actions.
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
Wall Street analysts forecast PHR stock price to rise
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 0.000
sliders
Low
24.00
Averages
29.09
High
35.00
Current: 0.000
sliders
Low
24.00
Averages
29.09
High
35.00
Piper Sandler
Overweight
to
Neutral
downgrade
$23 -> $12
AI Analysis
2026-05-28
Reason
Piper Sandler
Price Target
$23 -> $12
AI Analysis
2026-05-28
downgrade
Overweight
to
Neutral
Reason
Piper Sandler downgraded Phreesia to Neutral from Overweight with a price target of $12, down from $23.
Piper Sandler
Jessica Tassan
Overweight
to
Neutral
downgrade
$23 -> $12
2026-05-28
Reason
Piper Sandler
Jessica Tassan
Price Target
$23 -> $12
2026-05-28
downgrade
Overweight
to
Neutral
Reason
Piper Sandler analyst Jessica Tassan downgraded Phreesia to Neutral from Overweight with a price target of $12, down from $23. Phreesia is cutting costs to find profitability, but without a clear path back to durable organic revenue growth, notes the analyst, who is \"wary of this strategy\" in healthcare IT.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for PHR
Unlock Now

Valuation Metrics

The current forward P/E ratio for Phreesia Inc (PHR.N) is 14.58, compared to its 5-year average forward P/E of 0.35. For a more detailed relative valuation and DCF analysis to assess Phreesia Inc's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
0.35
Current PE
14.58
Overvalued PE
189.89
Undervalued PE
-189.18

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
-25.86
Current EV/EBITDA
11.31
Overvalued EV/EBITDA
94.11
Undervalued EV/EBITDA
-145.82

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
5Y Average PS
4.46
Current PS
1.27
Overvalued PS
8.06
Undervalued PS
0.87

Financials

AI Analysis
Annual
Quarterly

Whales Holding PHR

G
Granahan Investment Management, LLC
Holding
PHR
+36.68%
3M Return
D
Deerfield Management Company, L.P.
Holding
PHR
+19.41%
3M Return

Trading Trends

    Insider
    Hedge Fund
    Congress Trading

People Also Watch

Frequently Asked Questions

What is Phreesia Inc (PHR) stock price today?

The current price of PHR is 10.95 USD — it has decreased -1.35

What is Phreesia Inc (PHR)'s business?

Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.

What is the price predicton of PHR Stock?

Wall Street analysts forecast PHR stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for PHR is29.09 USD with a low forecast of 24.00 USD and a high forecast of 35.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

What is Phreesia Inc (PHR)'s revenue for the last quarter?

Phreesia Inc revenue for the last quarter amounts to 130.94M USD, increased 12.94

What is Phreesia Inc (PHR)'s earnings per share (EPS) for the last quarter?

Phreesia Inc. EPS for the last quarter amounts to 0.05 USD, decreased -171.43

How many employees does Phreesia Inc (PHR). have?

Phreesia Inc (PHR) has 1789 emplpoyees as of July 08 2026.

What is Phreesia Inc (PHR) market cap?

Today PHR has the market capitalization of 676.84M USD.